• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.

作者信息

Hughes J, Ward C J, Peral B, Aspinwall R, Clark K, San Millán J L, Gamble V, Harris P C

机构信息

MRC Molecular Haematology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK.

出版信息

Nat Genet. 1995 Jun;10(2):151-60. doi: 10.1038/ng0695-151.

DOI:10.1038/ng0695-151
PMID:7663510
Abstract

Characterization of the polycystic kidney disease 1 (PKD1) gene has been complicated by genomic rearrangements on chromosome 16. We have used an exon linking strategy, taking RNA from a cell line containing PKD1 but not the duplicate loci, to clone a cDNA contig of the entire transcript. The transcript consists of 14,148 bp (including a correction to the previously described C terminus), distributed among 46 exons spanning 52 kb. The predicted PKD1 protein, polycystin, is a glycoprotein with multiple transmembrane domains and a cytoplasmic C-tail. The N-terminal extracellular region of over 2,500 aa contains leucine-rich repeats, a C-type lectin, 16 immunoglobulin-like repeats and four type III fibronectin-related domains. Our results indicate that polycystin is an integral membrane protein involved in cell-cell/matrix interactions.

摘要

相似文献

1
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.
Nat Genet. 1995 Jun;10(2):151-60. doi: 10.1038/ng0695-151.
2
Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).与常染色体显性多囊肾病基因(PKD1和PKD2)同源的基因。
Eur J Hum Genet. 1999 Dec;7(8):860-72. doi: 10.1038/sj.ejhg.5200383.
3
A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1).
Genomics. 1994 Nov 1;24(1):27-33. doi: 10.1006/geno.1994.1578.
4
Transmembrane domain analysis of polycystin-1, the product of the polycystic kidney disease-1 (PKD1) gene: evidence for 11 membrane-spanning domains.多囊肾病1(PKD1)基因产物多囊蛋白-1的跨膜结构域分析:11个跨膜结构域的证据。
Biochemistry. 2003 Nov 11;42(44):13035-48. doi: 10.1021/bi035074c.
5
Polycystic kidney disease. 1: Identification and analysis of the primary defect.多囊肾病。1:原发性缺陷的识别与分析
J Am Soc Nephrol. 1995 Oct;6(4):1125-33. doi: 10.1681/ASN.V641125.
6
Autosomal dominant polycystic kidney disease: molecular analysis.
Hum Mol Genet. 1995;4 Spec No:1745-9. doi: 10.1093/hmg/4.suppl_1.1745.
7
Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families.希腊多囊肾病家族队列中的新型PKD1缺失和错义变异
Eur J Hum Genet. 2001 Sep;9(9):677-84. doi: 10.1038/sj.ejhg.5200696.
8
Predictions for polycystin.
Nat Genet. 1995 Jun;10(2):123-4. doi: 10.1038/ng0695-123.
9
Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium.
Cell. 1995 Apr 21;81(2):289-98. doi: 10.1016/0092-8674(95)90339-9.
10
A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for PKD2.一个与多囊肾病1基因(PKD1)相似的基因定位于4号染色体长臂2区2带:多囊肾病2基因(PKD2)的一个候选基因。
Genomics. 1996 Nov 15;38(1):1-4. doi: 10.1006/geno.1996.0584.

引用本文的文献

1
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan.常染色体显性多囊肾病的治疗:超越托伐普坦
Curr Opin Nephrol Hypertens. 2025 Sep 1;34(5):368-374. doi: 10.1097/MNH.0000000000001101. Epub 2025 Jul 4.
2
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.常染色体显性多囊肾病:从发病机制到类器官疾病模型
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
3
Pathogenic variants in the polycystin pore helix cause distinct forms of channel dysfunction.
多囊蛋白孔螺旋中的致病性变异会导致不同形式的通道功能障碍。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2421362122. doi: 10.1073/pnas.2421362122. Epub 2025 Jun 12.
4
Ion channel function of polycystin-2/polycystin-1 heteromer revealed by structure-guided mutagenesis.结构导向诱变揭示的多囊蛋白-2/多囊蛋白-1异源二聚体的离子通道功能
FEBS Lett. 2025 Jun;599(12):1649-1668. doi: 10.1002/1873-3468.70059. Epub 2025 May 12.
5
Bone mineral density and microarchitecture improvement in a young patient with Hajdu-Cheney syndrome and autosomal dominant polycystic kidney disease treated with alendronate.使用阿仑膦酸盐治疗的一名患有哈-切综合征和常染色体显性遗传性多囊肾病的年轻患者的骨矿物质密度和微结构改善情况
Bone Rep. 2025 Mar 24;25:101838. doi: 10.1016/j.bonr.2025.101838. eCollection 2025 Jun.
6
Physiologic mechanisms underlying polycystic kidney disease.多囊肾病的生理机制。
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
7
An extracellular vesicle based hypothesis for the genesis of the polycystic kidney diseases.一种基于细胞外囊泡的多囊肾病发病机制假说。
Extracell Vesicle. 2024 Dec;4. doi: 10.1016/j.vesic.2024.100048. Epub 2024 Jul 26.
8
Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids.腺嘌呤碱基编辑器纠正了人诱导多能干细胞和肾类器官中的常染色体显性多囊肾病点突变。
Adv Biotechnol (Singap). 2024 Jun 11;2(2):20. doi: 10.1007/s44307-024-00026-8.
9
Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.通过高通量筛选和计算生物物理学定义多囊蛋白药效团
bioRxiv. 2025 Jan 17:2025.01.13.632808. doi: 10.1101/2025.01.13.632808.
10
Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.托伐普坦在常染色体显性多囊肾病中的安全性;聚焦于特异质性药物性肝损伤风险。
Toxicol Sci. 2025 Jan 1;203(1):11-27. doi: 10.1093/toxsci/kfae142.